These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 23463940)
1. Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography. Pan J; Lau J; Mesak F; Hundal N; Pourghiasian M; Liu Z; Bénard F; Dedhar S; Supuran CT; Lin KS J Enzyme Inhib Med Chem; 2014 Apr; 29(2):249-55. PubMed ID: 23463940 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of (18)F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography. Lau J; Pan J; Zhang Z; Hundal-Jabal N; Liu Z; Bénard F; Lin KS Bioorg Med Chem Lett; 2014 Jul; 24(14):3064-8. PubMed ID: 24878197 [TBL] [Abstract][Full Text] [Related]
3. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides. Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675 [TBL] [Abstract][Full Text] [Related]
4. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging. Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of Zhang Z; Lau J; Zhang C; Colpo N; Nocentini A; Supuran CT; Bénard F; Lin KS J Enzyme Inhib Med Chem; 2017 Dec; 32(1):722-730. PubMed ID: 28385087 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties. Iikuni S; Okada Y; Shimizu Y; Watanabe H; Ono M Mol Pharm; 2021 Mar; 18(3):966-975. PubMed ID: 33472371 [TBL] [Abstract][Full Text] [Related]
7. PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide. Iikuni S; Watanabe H; Shimizu Y; Nakamoto Y; Ono M PLoS One; 2020; 15(12):e0243327. PubMed ID: 33296398 [TBL] [Abstract][Full Text] [Related]
8. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. Touisni N; Maresca A; McDonald PC; Lou Y; Scozzafava A; Dedhar S; Winum JY; Supuran CT J Med Chem; 2011 Dec; 54(24):8271-7. PubMed ID: 22077347 [TBL] [Abstract][Full Text] [Related]
9. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors. Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Nakai M; Pan J; Lin KS; Thompson JR; Nocentini A; Supuran CT; Nakabayashi Y; Storr T J Inorg Biochem; 2018 Aug; 185():63-70. PubMed ID: 29778927 [TBL] [Abstract][Full Text] [Related]
11. Acetazolamide-based [ More KN; Lee JY; Kim DY; Cho NC; Pyo A; Yun M; Kim HS; Kim H; Ko K; Park JH; Chang DJ Bioorg Med Chem Lett; 2018 Mar; 28(5):915-921. PubMed ID: 29422388 [TBL] [Abstract][Full Text] [Related]
12. Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship. Gao R; Liao S; Zhang C; Zhu W; Wang L; Huang J; Zhao Z; Li H; Qian X; Xu Y Eur J Med Chem; 2013 Apr; 62():597-604. PubMed ID: 23429054 [TBL] [Abstract][Full Text] [Related]
13. Development of the Iikuni S; Tanimura K; Watanabe H; Shimizu Y; Saji H; Ono M Mol Pharm; 2019 Apr; 16(4):1489-1497. PubMed ID: 30892905 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds. Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity. Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177 [TBL] [Abstract][Full Text] [Related]
16. Radiosynthesis of three [11C]ureido-substituted benzenesulfonamides as PET probes for carbonic anhydrase IX in tumors. Asakawa C; Ogawa M; Kumata K; Fujinaga M; Yamasaki T; Xie L; Yui J; Kawamura K; Fukumura T; Zhang MR Bioorg Med Chem Lett; 2011 Dec; 21(23):7017-20. PubMed ID: 22014831 [TBL] [Abstract][Full Text] [Related]
17. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma. Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076 [TBL] [Abstract][Full Text] [Related]
18. Fluorine-18 click radiosynthesis and microPET/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX. Jia L; Li X; Cheng D; Zhang L Bioorg Med Chem; 2019 Mar; 27(5):785-789. PubMed ID: 30683555 [TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984 [TBL] [Abstract][Full Text] [Related]
20. Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX. Sharma A; Tiwari M; Supuran CT J Enzyme Inhib Med Chem; 2014 Apr; 29(2):292-6. PubMed ID: 23488741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]